UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES
13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. ____)*
INVITROGEN CORPORATION
(Name of Issuer)
COMMON STOCK, $.01 par value
(Title of Class of Securities)
46185R 10 0
(CUSIP Number)
February 3, 2000
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the Rule pursuant to which
this Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
---------------------
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that Section of
the Act, but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
page 2 of 6
SCHEDULE 13G
- ----------------------------------
CUSIP NO. 46185R 10 0
- ----------------------------------
1 Names of Reporting Persons/IRS Identification Nos. of above Persons
(Entities Only)
James R. Hudson, Jr.
- -------------------------------------------------------------------------------
2 Check the Appropriate Box if a
Member of a Group (a) [ ] (b) [ ]
Not Applicable
- -------------------------------------------------------------------------------
3 SEC Use Only
- -------------------------------------------------------------------------------
4 Citizenship or Place of Organization
United States of America
- -------------------------------------------------------------------------------
Number of 5 Sole Voting Power
Shares 2,594,800
-------------------------------------------------------
6 Shared Voting Power
Beneficially
0
-------------------------------------------------------
Owned By 7 Sole Dispositive Power
Each 2,594,800
-------------------------------------------------------
8 Shared Dispositive Power
Reporting
0
Person With
- -------------------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
2,594,800
- -------------------------------------------------------------------------------
10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares [ ]
- -------------------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
10.1%
- -------------------------------------------------------------------------------
12 Type of Reporting Person
IN
- -------------------------------------------------------------------------------
<PAGE>
page 3 of 6
SCHEDULE 13G
- --------------------------------
CUSIP NO. 46185R 10 0
- --------------------------------
ITEM 1(a). Name of Issuer:
Invitrogen Corporation
ITEM 1(b). Address of Issuer's Principal Executive Offices:
1600 Faraday Avenue
Carlsbad, CA 92008
ITEM 2(a). Name of Person Filing:
James R. Hudson, Jr.
ITEM 2(b). Address of Principal Business Office Or, If None, Residence:
c/o Research Genetics
2130 Memorial Parkway, S.W.
Huntsville, AL 35801
ITEM 2(c). Citizenship:
James R. Hudson, Jr., is a citizen of the United States of America
ITEM 2(d). Title of Class of Securities:
Common Stock, $0.01 par value
ITEM 2(e). CUSIP Number:
46185R 10 0
ITEM 3. If this statement is filed pursuant to rule 13d-1(b), or
13d-2(b) or (c), check whether the person filing is a:
Not Applicable.
<PAGE>
page 4 of 6
SCHEDULE 13G
- ---------------------------------
CUSIP NO. 46185R 10 0
- --------------------------------
ITEM 4. OWNERSHIP.
Provide the following information regarding the aggregate
number and percentage of the class of securities of the issuer
identified in Item 1.
(a) Amount beneficially owned: 2,594,800
(b) Percent of class: 10.1%
(c) Number of shares as to which such person has:
(i) Sole power to vote or direct the vote: 2,594,800
(ii) Shared power to vote or direct the vote: 0
(iii) Sole power to dispose or to direct the disposition of:
2,594,800
(iv) Shared power to dispose or to direct the disposition of:
0
ITEM 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following [ ].
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable.
ITEM 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company.
Not Applicable.
<PAGE>
page 5 of 6
SCHEDULE 13G
- --------------------------------
CUSIP NO. 46185R 10 0
- --------------------------------
ITEM 8. Identification and Classification of Members of the Group.
Not Applicable.
ITEM 9. Notice of Dissolution of Group.
Not Applicable.
ITEM 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
<PAGE>
page 6 of 6
SCHEDULE 13G
- --------------------------------
CUSIP NO. 46185R 10 0
- --------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 4, 2000 James R. Hudson, Jr.
-----------------------
James R. Hudson, Jr.
